top of page

3rd annual GPRT Summit- Market Access, Pricing & Reimbursement

01-02 February 2024
You should not miss this annual opportunity if you are - Chiefs, Directors, Heads, Senior Manager, Leaders and Executives from:
Conference
  • Clinical Operations

  • Clinical Developments/Research

  • Clinical Trials/ Program/ Clinical Project/Operations

  • Study and Feasibility Management

  • Medical Operations/Monitoring Operations

  • International Clinical Research

  • Patient Recruitment & Retention

  • Medical Affairs/ Medical Advisors/ MSL

  • Data Management

  • Compliance and Regulatory

  • Patient Enrolment/ Patient Advocacy/ Patient Executive

  • Therapeutic Lead

  • Study Lead/ Study Delivery/ Study Director/PI

  • Clinical Site Management

  • Digital/Medical Technologies

For group discounts and complete details contact us.

WHO SHOULD ATTEND

CONFERENCE BENEFITS

  • Get engaged with the professionals from leading industries

  • 20+ Keynote Sessions

  • 5+ Workshop sessions

  • Round Table Discussions – Brain storming

  • Panel Discussions – Interact Directly with the Panellists to raise your challenges

  • More than 10 Case Studies presenting by the top experts from across the industry

  • 13+ hours Networking Opportunity

  • Benchmarking Opportunities

  • One-to-one interactions

  • Tea/Coffee Breaks, Social Events and Cocktail Reception

  • .…and much more!

Conference
Opportunity to meet top expert and decision makers from Pharma, Biotech, Medical Devices, Clinical Sites and CROs industry under one Roof

OVERVIEW

Conference

A rewarding opportunity to join OECT Summit in three key locations in Berlin Germany, Toronto Canada and Philadelphia USA.

OECT Summit is targeted for professionals who are always seeking for new opportunities, visionary ways of conducting performance. Study Feasibility and Patient recruitment & retention offer major challenges to the clinical researcher, clinical project managers, clinical operation managers with potential for significant impact on timelines, budgets, CRA talent rejuvenation, collaborations & partnerships and ultimately the scientific integrity of the trial itself.

Many factors affect the recruitment of patients and difficulty in finding suitable patients is driving the development of many innovative methods for accessing new patient groups. How ‘Big Data Analytics and Date Driven Decision Making’ can have a significant impact in clinical trials. The artificial intelligence, remote trials/ virtual trials, decentralised trials, connected health and digitalisation means that new technologies and changing strategies for communication can be used to engage patients at early development stage, have feasibility right at first, accelerate site selection initiation process & great effect to reach out to patients directly.

Additionally, outreach through patient advocacy groups, social service agencies are becoming more important to communicate with patients viable for trial participation as well as for those already enrolled in clinical trials. How to maximise the benefit of this approach and ensure our regulatory obligations are appropriately met will be the subject of several sessions during the summit.

Don’t forget to check our OECT Summit editions in Canada and USA.

Blue gradient
Conference hall

KP Morgan specializes in clinical trials, SFE, commercial excellence and Healthcare innovation events, hosting events in various locations such as Canada, USA, Europe and Dubai.

KP-Morgan Conferences have provided platforms for debate across many industry sectors including: Telecommunication, banking & financial services, retail and FMCG, investments, pharmaceuticals, IT, chemical & petro chemical.

Many argue that the innovation process cannot be managed because innovation is supposed to be about creativity and cannot be predicted. We believe in KP-Morgan that Innovation is not only about being creative and inventive; innovation is a collaborative process where ideas are taken and managed through to value-adding market introduction.

The consistent high quality of our events has given rise to a reputation for excellence, ensuring that KP-Morgan conferences provide the most fertile ground for participants to gain up-to-the-minute market intelligence and invaluable opportunities to network and generate new business.

About KP-Morgan Group

Conference

AGENDA: TOPICS AT GLANCE

Keynote Presentation, Interactive Discussions, Case Studies, Brain Storming and Round Table Discussions

OPEX, Study Feasibility and Site Selection, Activation, Management
  • Tools to effectively plan, manage and track your clinical study portfolio

  • How to simplify CT management workflows

  • Data capture through BOYD & virtual

  • Changing roles of Clinical Project Managers

  • Study Feasibility: Right at first

  • How to use patient insights to improve clinical trial design and operations

  • Health Equity and diversity in Clinical Trials

  • Is there a need of digital enabled CRAs

  • What technologies shall sites use to meet the hybrid or virtual approach

  • DCTs – Why a way to the future

  • Remote Monitoring: Maximising the value and what does future hold

  • Biomarkers, trial, endpoints and remote monitoring tools

  • Risk Based Approach: Why change to RBM?

  • Evolution of data science in data management

  • Importance of virtual & remote trials

  • Cross Table talk between Sponsor & Sites

  • Site Inspection Readiness

  • How to have organized study programs

  • Site Selection, Activation & Management

  • Study Startup and resource allocations

  • Research-naive sites & Site staff training & motivation

  • Minimizing the unpredictable environment on budget perspective

  • Minimizing the confusions between sponsors & physicians/sites/labs

  • Digitalisation of site selection & activation

  • KPIs – Speed, Cheap & Quantity

  • Challenges in Clinical Development – Adapting into the new landscape

  • Growing SOPs complexity

  • Engagement of Investigators in Business Models or Clinical Trial protocols

  • Patient Involvement in Clinical Trial Design

Conference
Blue gradient

PATIENT EMPOWERMENT: AS PARTER

  • Patient journey mapping

  • How to retain patients in long run trials

  • Engaging Patients in Recruitment Strategies in Clinical Trial

  • Patient awareness program

  • Holistic approach to patient recruitment

  • Patient journey mapping

  • Case Study: Oncology Trials, Rare Diseases Trials, Diabetes Trials

  • Patient Centric Approaches

  • What role sites can play in patient recruitment

  • Patient recruitment online tools

  • Demonstrating Patient Insight from an early stage of drug development

  • Advancing use of patient centric platform trials

  • Patient Recruitment in Emerging countries and Challenges for Global Trials

  • Data driven patient recruitment

CLINICAL TECHNOLOGIES & TRENDS

  • eClinical Outcome Assessments/ePRO

  • (electronic Patient-Reported Outcome) Methods

  • A hybrid model for enablement of decentralized clinical trials and remote centralized monitoring (eSource)

  • How Technology & Real-time Data Can Enable Trial Success.

  • Role of wearables, AIs, Digitalisation, eHealth in clinical innovation

  • How to translate technology/databases knowledge into identification of patients

Philippe Auby

Philippe Auby

Former CEO & President | Otsuka Europe Development & Commercialisation

Karl-Ludwig Radek

Karl-Ludwig Radek

Associate Director, EMEA Strategic Account Lead, Global Clinical Operations | Janssen Cilag - Johnson & Johnsons

Emmanuel Jansa

Emmanuel Jansa

Chief Innovation Officer | iQlinical - Accelerating Clinical Trials

Imogen Cheese

Imogen Cheese

Director, Business Development | Imperial CRS

Wolfgang Summa

Wolfgang Summa

Head of CMO Informatics | Merck KGaA

Torsten Winkler

Torsten Winkler

Managing Director, IVD, Medical Device and medical software industry | MaganaMed GmbH

Siddharth Chachad

Siddharth Chachad

EVP & Head – Global Clinical Management | Dr Reddys

Wolfgang Schleifer

Wolfgang Schleifer

Head Digital Delivery | Novartis

Michaela Vancova

Michaela Vancova

Managing Director | Clinical Research Center(SMO)

Zina Sarif

Zina Sarif

Clinical Research Associate, Late Dev Oncology | AstraZeneca

Artem Andrianov

Artem Andrianov

Managing Director and Founder | Cyntegrity

Nigel Goodman

Nigel Goodman

CEO | Gaea OU

Roger Legtenberg

Roger Legtenberg

Senior Partner & Head of Benelux Region | Admedicum

Heike Roeder

Heike Roeder

Lead Digital Quality, Risk Advisory Life Science | Deloitte

Andrea Ochoa

Andrea Ochoa

Vice President Global Study Start Up | Premier Research

Tobias Kruse

Tobias Kruse

Managing Director | Trials24 GmbH

Loic Notelet

Loic Notelet

Patient Engagement Lead Europe | Sanofi

Nadir Ammour

Nadir Ammour

Global Lead, Clinical Innovation & Partnership | Sanofi

Marta Garcia Manrique

Marta Garcia Manrique

Chief Patient Officer | Servier

Alfred Pawson

Alfred Pawson

Director Information Technology | DnA Business Consulting

Eirini Schlosser

Eirini Schlosser

Co-founder and CEO | Dyania Health

Richard Young

Richard Young

Vice President, Vault CDMS Strategy | Veeva

SPEAKERS AND PARTNERS

Well known industry leader and emerging talents

gradient_bg.png

REGISTER

Basic
  • One Entry Pass to in-person Two days conference

  • Conference Material

  • Business Lunch

  • Tea and snacks

  • Cocktail Reception

Premium
  • Two Entry Passes to Two days conference and pre-conference workshop

  • One complimentary pass

  • Business Lunch

  • Tea and snacks

  • Cocktail Reception

Gold
  • One Entry Pass to in-person Two days conference

  • Two-night Accommodation

  • Certificate of Attendance

  • Conference Material

  • Business Lunch

  • Tea and snacks

  • Cocktail Reception

VENUE

DoubleTree by Hilton Philadelphia – Center City

237 S Broad Street, Philadelphia, PA 1910

CONTACT US

Got a question?

STEPHEN PATEL

Telephone: +12675156114

  • X
  • FB(1)
  • LinkedIn(1)
bottom of page